Curant’s Managing Director of Operations, Dave Cunnold, is featured in Managed Healthcare Executive providing insight on the evolution of the healthcare experience for patients with chronic conditions. The successful patient journey has evolved due to the transition to value-based care and the need to drive better health outcomes. What works now is an approach that is personalized and includes ongoing education about the medication therapy itself, as well as the importance of medication adherence.
The top four components for a better patient experience
- Mutual investment in the relationship between prescribers and pharmacy management teams. This includes a warm handoff from the prescriber to the pharmacy team.
- Incentive alignment across the healthcare continuum so that all resources are squarely focused on coordinated condition management.
- Dedicated resources like our patient care coordinators focused on individual patients and the development of strong, ongoing relationships.
- Services that make care easy for the patient, including personalized medication packaging, technology solutions and flawless medication delivery systems.
The proof that a better patient journey works
We partner with other providers to improve the health outcomes and lives of our patients. Through numerous studies including one recently completed with the 1917 Clinic, a Ryan White grantee at UAB, we have been able to show that our personalized medication management protocols improve adherence, increase the number of patients who are virally suppressed and reduce the average treatment cost.
The 1917 Clinic, a Ryan White grantee at the University of Alabama at Birmingham (UAB), serves a large patient population that struggles with adherence. Earlier this year, UAB clinicians completed analysis of 652 HIV patients over a 38-month period who engaged in medication management protocols provided by Curant Health as part of their HIV treatment plans. Of 157 patients who did not have suppressed viral loads at enrollment, 103 achieved viral suppression during follow-up tests, which ranged from six weeks to one year after enrollment. That’s a statistically significant increase in the proportion of patients achieving viral suppression.
To read Dave’s article on the patient journey, visit Managed Healthcare Executive.